Deciphex

Deciphex Welcomes Dr. Pierre Moulin as Chief Scientific Officer to Help Shape the Future of Pathology AI

Deciphex, an innovator in Pathology AI, announces the strategic appointment of Dr. Pierre Moulin as Chief Scientific Officer.  Dr Moulin, MD, PhD, MBA has established himself as a distinguished physic...

Deciphex and Xybion Digital join forces to Infuse the Power of Micropathology Digital Slide Reading into Dynamic Non-clinical Study LIMS Workflows

PRINCETON, NJ and DUBLIN, IRELAND / ACCESSWIRE / September 14, 2023 / Deciphex, a trailblazer in digitizing and networking global pathologists, has joined forces with Xybion, a global leader in unifie...

Diagnexia Expands Pathology Services with State-of-the-Art Accessioning Facility in Toronto, Revolutionising Digital Pathology and Enhancing Patient Care

Diagnexia Canada Limited, owned by Deciphex Limited and internationally recognized as a leading provider of pathology services, is delighted to announce the launch of its cutting-edge accessioning fac...

Deciphex: Patholytix Introduces Digital Pathology Review And Scoring In A Single Platform For The First Time

With Patholytix 3.0, Deciphex overcomes one of the last barriers to full-scale adoption of digital pathology. For the first time, users can review and score non-clinical studies on a single platform. ...

Deciphex Secures €3.9m Funding to Boost Digital Pathology and AI Services

Deciphex, a leading provider of pathology software and services, announced today a further €3.9m in funding bringing its full Series B round tally to €14.4m. The additional investment, led by Seroba L...